In VivoAmid mounting global concerns over uncontrolled hypertension and its ties to cardiorenal and metabolic disorders, Pennsylvania-based biotech Mineralys Therapeutics is making waves with its novel aldos
Pink SheetThe European Medicines Agency is exploring how to help drug companies develop treatments for systemic sclerosis (SSc), a rare connective tissue disorder associated with high morbidity and mortality bu
ScripUS/Swiss biotech GlycoEra AG announced a $130m series B financing on 27 May that it says will enable it to advance its first protein-degradation drug candidate through Phase II proof of concept as pre
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On